Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 4Phase 1/2 2Phase 1 1

Status

Completed 6

Sponsor Class

INDUSTRY 6OTHER 4OTHER_GOV 1NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Dermatologic 6

Conditions

Keratosis, Actinic 5Carcinoma, Basal Cell 2Warts 1Carcinoma, Squamous Cell 1Bowen's Disease 1

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × Photochemotherapy × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT00472108 2024-08-05

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Galderma R&D

Phase 3 Completed
65 enrolled 15 charts
Dermatologic

Carcinoma, Basal Cell

NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Biofrontera Bioscience GmbH

Phase 3 Completed
87 enrolled 21 charts
Dermatologic

Keratosis, Actinic

NCT00306800 2021-02-18

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Galderma R&D

Phase 3 Completed
80 enrolled
Dermatologic

Keratosis, Actinic

NCT00308854 2008-04-11

Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK

photonamic GmbH & Co. KG

Phase 3 Completed
107 enrolled
Dermatologic

Keratosis, Actinic

NCT00308867 2008-04-11

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

photonamic GmbH & Co. KG

Phase 3 Completed
349 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡